7187379870

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Serum Biochemical Markers in Ovarian Cancer Ã?Â?Ã?Â?Ã?Â?Ã?Â? A Review

Author(s): Harpreet Kaur and Jagmohan Singh

Ovarian cancer is the most frequent cause of death from gynaecological cancers, characterized by few early symptoms, diagnosis at an advanced stage as well as poor prognosis. A number of cell surface antigens and serum proteins are produced by ovarian tumors and can be assayed using monoclonal antibodies. Some of these assays have been applied clinically as markers of disease status and are useful in the diagnosis of recurrent ovarian cancer. CA-125 is currently the serum marker most widely used to monitor therapeutic response and to detect disease recurrence in patients treated for epithelial ovarian cancer.Among the other new tumor markers, M-CSF, HE4,mesotehlin seem to be promising. The serial measurement of complementary serum markers can improve the use of marker screening for epithelial ovarian cancer.


Share this       
Google Scholar citation report
Citations : 627

Research & Reviews in BioSciences received 627 citations as per Google Scholar report

Indexed In

  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Scholarsteer
  • Secret Search Engine Labs
  • Euro Pub
  • ICMJE

View More